Research programme: peptide antibacterials - SpiderBiotech

Drug Profile

Research programme: peptide antibacterials - SpiderBiotech

Alternative Names: Peptide antibiotics - SpiderBiotech; SB-006; SB006-based antimicrobial peptides - SpiderBiotech; Tetrabranched antibacterial peptides - SpiderBiotech/NeED Pharmaceuticals

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SpiderBiotech
  • Class Peptides
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Gram-negative infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-negative-infections in Italy
  • 22 Apr 2008 Antimicrobial & pharmacodynamic data from a preclinical trial in Gram-negative infections presented at the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2008)
  • 31 Dec 2005 Preclinical trials in Gram-negative infections in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top